相关实验视频
Updated: May 5, 2026

07:54
Cholesterol Efflux Assay
Published on: March 6, 2012
29.4K
在胆固醇排放中,一种可用药物的G蛋白检查点
bioRxiv : the preprint server for biology
|February 27, 2026
概括
脂质相关的巨细胞通过未能清除脂质来驱动免疫代谢疾病. 针对GIV依赖车恢复胆固醇排放,逆转斑块积累,并建立逆胆固醇运输作为一种新疗法.
科学领域:
- 免疫代谢和动脉样硬化研究研究
- 巨细胞生物学和脂质代谢
背景情况:
- 像肥胖和动脉样硬化等免疫代谢疾病源于脂质相关巨细胞 (LAMs) 积累过量的脂质.
- 反向胆固醇运输 (RCT) 是巨细胞清除脂质的主要途径,目前不是一个可行的治疗标.
研究的目的:
- 为了确定 LAM 功能障碍背后的分子机制,驱动斑块进展.
- 探索GIV (CCDC88A) 作为恢复RCT和治疗免疫代谢疾病的潜在治疗点.
主要方法:
- 用人类斑块转录组进行集成系统建模,以确定关键的LAM亚群.
- 在小鼠模型中利用骨髓细胞特异性GIV删除来评估其对斑块负担和脂质调动的影响.
- 研究了GIV在捕获ABCA1和调节Gαi-cAMP信号传递中的机制性作用.
主要成果:
- 鉴定出GIV是RCT的分子制动,其删除减少了大动脉斑块负担并调动了脂质.
- 已经证明GIV可以捕获ABCA1载体并抑制cAMP/PKA-CREB信号,从而抑制胆固醇排放.
- 破坏GIV●Gαi检查点恢复了ABCA1活动,重新编程了LAM,并显著降低了模拟的斑块进展风险.
结论:
- 通过准GIV●Gαi-cAMP检查点来恢复RCT,为免疫代谢疾病提供了一种新的,巨固有的治疗策略.
- 这种方法成功地恢复了胆固醇排放,而像他类药物和β-阻断剂这样的传统疗法失败了.
- 这些发现确立了RCT恢复作为一种可用药物的范式,用于治疗因巨细胞功能障碍脂质代谢驱动的疾病.
相关概念视频
GPCR Desensitization
6.1K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.1K
G-Protein Gated Ion Channels
5.5K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
5.5K
GPCRs Regulate Adenylyl Cylase Activity
6.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.9K
IP3/DAG Signaling Pathway
12.5K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.5K
Transducer Mechanism: G Protein–Coupled Receptors
9.0K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
9.0K
Carrier-Mediated Transport
1.6K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.6K

